Interaction Check

This page cannot be displayed because your browser has been configured to disable JavaScript, also known as "Active Scripting".Please change your settings and refresh the page.

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

MultiCheck Results - 6 Interactions

Monitor/Modify Tx
Abilify Asimtufii (aripiprazole bimonthly injection) + colesevelam (generic)
Monitor/Modify Tx aripiprazole bimonthly injection + colesevelam monitor glucose in type 2 diabetes mellitus pts: combo may decr. antidiabetic agent efficacy (antagonistic effects)
Abilify Asimtufii (aripiprazole bimonthly injection) + Loxitane (loxapine)
Monitor/Modify Tx aripiprazole bimonthly injection + loxapine monitor BP: combo may incr. risk of CNS depression, psychomotor impairment, hyperthermia, extrapyramidal symptoms, hypotension, including orthostasis, syncope (additive effects)
Abilify Asimtufii (aripiprazole bimonthly injection) + Norvasc (amlodipine)
Monitor/Modify Tx aripiprazole bimonthly injection + amlodipine monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)
Abilify Asimtufii (aripiprazole bimonthly injection) + Sdamlo (amlodipine)
Monitor/Modify Tx aripiprazole bimonthly injection + amlodipine monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)
Loxitane (loxapine) + Norvasc (amlodipine)
Monitor/Modify Tx loxapine + amlodipine monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)
Loxitane (loxapine) + Sdamlo (amlodipine)
Monitor/Modify Tx loxapine + amlodipine monitor BP: combo may incr. risk of hypotension, including orthostasis, syncope (additive effects)
Additional Considerations
colesevelam
give oral drugs at least 4h before colesevelam; bile acid sequestrant may delay or decr. absorption of concomitant oral drugs
aripiprazole bimonthly injection in Abilify Asimtufii
drug interactions apply only to Abilify Asimtufii (aripiprazole bimonthly injection); see other aripiprazole products for potentially relevant interactions aripiprazole is a substrate of CYP2D6 and CYP3A4; drug interaction guidance may vary with CYP450 inhibitors if patient is CYP2D6 poor metabolizer (PM)